# 6580
Along with the statements tweeted earlier today by the World Health Organization (see WHO: Coronavirus Not SARS), we have an assessment just released from the ECDC that states:
Further investigations are needed to fully understand the novel coronavirus and the public health implications. However, based on the available information, ECDC assesses the current risk as low.
In their statement they also point out that this novel coronavirus is `not genetically similar to the SARS coronavirus’ and `There is no evidence of person to person transmission’.
Coronavirus: collaboration and surveillance the key to early detection and understanding the risk
25 Sep 2012
ECDC
European, international and national public health authorities have been working closely together since the identification of two cases with a novel coronavirus became known. One case has died in Saudi Arabia and the second is in intensive care in a London hospital.
This newly identified coronavirus is not genetically similar to the SARS coronavirus and does not signal the start of a new SARS outbreak. There is no evidence of person to person transmission, which was the case with SARS, and the symptom presentation is also different. Coronaviruses can cause quite mild symptoms, similar to the common cold, or more severe disease as witnessed by the 2003 international SARS outbreak.
Further investigations are needed to fully understand the novel coronavirus and the public health implications. However, based on the available information, ECDC assesses the current risk as low. The only way we can build a proper understanding of the virus is through coordinated international surveillance and laboratory testing. The value of laboratories has been demonstrated by the excellent work done by the Health Protection Agency (HPA) laboratories in the UK and the Erasmus University Medical Centre in Rotterdam, the Netherlands.
There are in place plans and procedures in all public health authorities and international organisations for managing events where there is a little- or un-known disease or virus. These range from sharing the genome of the virus between countries to ensure rapid laboratory identification to regular conference calls of public health officials. This is, in part, due to the legacy of the 2003 international SARS (severe acute respiratory syndrome) outbreak. We now have better surveillance systems and a network of expert laboratories on imported viral diseases.
Related Post:
- The Many Flavors Of ILI
- WHO Coronavirus Update
- mBio: Coronavirus Has An Affinity For Multiple Hosts
- ECDC: Updated Novel Coronavirus Risk Assessment
- WHO Coronavirus Updates
- WHO: Background & Summary Of Coronavirus Cases
- WHO Coronavirus Update: 9 Confirmed Cases
- WHO Corrects Coronavirus Statement
- Referral: CIDRAP News Summarizes The Coronavirus Story
- Branswell On Expanded Surveillance For The Coronavirus
- ECDC Updates Their Coronavirus Risk Assessment
- Hong Kong’s Coronavirus Response
- Novel Coronavirus: More Questions Than Answers
- WHO Announces Additional Coronavirus Cases
- Saudi Arabian MOH Reports New Coronavirus Case
- Updated ECDC Risk Assessment On Coronavirus
- Saudi Arabia MOH Announces Third Coronavirus Case
- Referral: McKenna On The NEJM Coronavirus Report
- Hong Kong Boy Tests Negative For Coronavirus
- Hong Kong Investigating Possible Coronavirus Case
- Coronavirus `Closely Related’ To HK Bat Strains
- Coronavirus: WHO Update & Genome Sequence
- McKenna: Remembering SARS & The New Coronavirus
- Hospital: Danish Patients Negative For Coronavirus
- HPA Letter To NHS Staff On Coronavirus
- Lancet: Low Flu Vaccine Effectiveness
- ECDC Influenza Virus Characterization
- ECDC: Updated Novel Coronavirus Risk Assessment
- ECDC Updates Their Coronavirus Risk Assessment
- ECDC Risk Assessment: Dengue In Madeira
- WHO Europe: Revising Pandemic Preparedness Plans
- ECDC: Multidrug Resistant Infections Increasing In Europe
- Global Flu Surveillance Updates
- Updated ECDC Risk Assessment On Coronavirus
- ECDC: Influenza Virus Characterization – Sept 2012
- EID Journal: Challenges To Defining TDR-TB
- ECDC Report: Narcolepsy In Association With Pandemic Flu Vaccination
- ECDC Risk Assessment On DR Congo Ebola Outbreak
- H3N2v: CDC Update & ECDC Risk Assessment
- ECDC: Climatic Suitability For Dengue Transmission in Europe
- Updating The Cambodian `Mystery’ Illness
- ECDC: Risk Assessment On Edinburgh Legionella Outbreak
- ECDC Response Plan To Multi-Drug Resistant Gonorrhea
- ECDC: Communicable Disease Threats -Week 23
- How The ECDC Will Spend Your Summer Vacation
- ECDC: Mapping Disease Vectors
- ECDC: Status & Importance Of Invasive Mosquito Breeds In Europe
- WHO-ECDC: Joint Report On Tuberculosis In Europe
- ECDC: Annual Risk Assessment On Seasonal Flu 2011-2012
- ECDC: Updated Novel Coronavirus Risk Assessment
- ECDC Updates Their Coronavirus Risk Assessment
- Updated ECDC Risk Assessment On Coronavirus
- ECDC Risk Assessment On DR Congo Ebola Outbreak
- H3N2v: CDC Update & ECDC Risk Assessment
- Pandemic Uncertainties
- ECDC: Risk Assessment On Edinburgh Legionella Outbreak
- 5.8 Mag. Quake Rocks Northern Italy
- UK: Civil Threat Risk Assessment
- ECDC: Annual Risk Assessment On Seasonal Flu 2011-2012
- ECDC Risk Assessment On H5N1 Transmissibility Studies
- UN Agency Warns On Global Seismic Risks
- ECDC: Rapid Risk Assessment On China’s H5N1 Fatality
- ECDC: Updated Risk Assessment On trH3N2 Virus
- ECDC Risk Assessment On trH3N2 Cases In North America
- IDDR: Stepping Up For Disaster Risk Reduction
- UNDP: Supercities At Seismic Risk
- A Look At Europe’s Seismic Risks
- ECDC: Risk Assessment For Remainder Of Flu Season
Widget by [ Iptek-4u ]